THE ANALYSIS OF MULTIPLE END-POINTS IN CLINICAL-TRIALS

被引：385
|
作者：
POCOCK, SJ
GELLER, NL
TSIATIS, AA
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
[2] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115
来源：
BIOMETRICS | 1987年 / 43卷 / 03期
关键词：
D O I：
10.2307/2531989
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：487 / 498
页数：12
相关论文
共 50 条
  • [41] Clinical trials - Multiple treatments, multiple end points, and multiple lessons
    Lauer, MS
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19): : 2575 - 2577
  • [42] Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
    Legro, RS
    Myers, E
    HUMAN REPRODUCTION, 2004, 19 (08) : 1697 - 1704
  • [43] END-POINTS IN CLINICAL-TRIALS OF RADIATION-THERAPY FOR INOPERABLE SQUAMOUS-CELL CARCINOMA, ADENOCARCINOMA, AND LARGE CELL (SAL) CARCINOMA OF THE LUNG
    COX, JD
    BAUER, M
    DIENERWEST, M
    PEREZ, CA
    SHIN, KH
    BYHARDT, RW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (02): : 105 - 106
  • [44] PRIMARY AND SECONDARY END-POINTS FOR HIV VACCINE EFFICACY TRIALS
    HOFF, R
    LAWRENCE, DN
    FISCHER, R
    VERMUND, S
    BARKER, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S49 - S49
  • [45] Surrogate end-points for treatment trials of hepatitis B virus
    Griffiths, P. D.
    REVIEWS IN MEDICAL VIROLOGY, 2010, 20 (04) : 199 - 201
  • [46] SURROGATE END-POINTS
    ELLENBERG, SS
    BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 457 - 459
  • [47] Challenges in idiopathic pulmonary fibrosis trials: the point on end-points
    Albera, C.
    EUROPEAN RESPIRATORY REVIEW, 2011, 20 (121): : 195 - 200
  • [48] Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma
    Kubota, Yuta
    Tanaka, Kazuhiro
    Kawano, Masanori
    Iwasaki, Tatsuya
    Itonaga, Ichiro
    Tsumura, Hiroshi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma
    Yuta Kubota
    Kazuhiro Tanaka
    Masanori Kawano
    Tatsuya Iwasaki
    Ichiro Itonaga
    Hiroshi Tsumura
    Scientific Reports, 12
  • [50] Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis
    Etekal, Tommy
    Koehn, Kelly
    Sborov, Douglas W.
    McClune, Brian
    Prasad, Vinay
    Haslam, Alyson
    Berger, Katherine
    Booth, Christopher
    Al Hadidi, Samer
    Abdallah, Al-Ola
    Goodman, Aaron
    Mohyuddin, Ghulam Rehman
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (05) : 587 - 594
12345